MicroRNA 6724-4 (MIR6724-4)

MicroRNA 6724-4 is a short (20–24 nucleotide) non-coding RNA molecule transcribed by RNA polymerase II as part of a primary transcript that undergoes sequential processing by Drosha and Dicer enzymes to generate the mature miRNA[1][7]. The mature MIR6724-4 is incorporated into a RNA-induced silencing complex (RISC), which binds to partially complementary sequences in target mRNAs and typically inhibits their translation or promotes their degradation[1][2][7]. As a member of the miRNA family, MIR6724-4 is implicated in fine-tuning gene expression that influences development, cell differentiation, metabolism, apoptosis, and immune function, and dysregulation of miRNAs is commonly observed in human disease, particularly cancer[2][7]. No direct evidence currently links MIR6724-4 to a specific disease, biomarker role, or therapeutic modality, but its classification and regulatory functions align with typical properties of human miRNAs. While no specific biomarkers for MIR6724-4 are known, miRNAs as a class are widely studied as stable non-invasive biomarkers for diagnostics, disease monitoring, and patient selection. Similarly, specific safety concerns for MIR6724-4 are not documented, but general challenges with miRNA-targeted therapeutics include off-target effects, delivery, immune activation, and toxicity.

Other names

hsa-mir-6724-4MIR6724-4microRNA 6724-4